GSK
GSK plcCompany with tickers: GSK, GLAXF
CIK
1131399
CUSIP
37733W204
Shares Outstanding
2,004,414,458
Website
https://www.gsk.com/
Investor Relations
https://www.gsk.com/investor-relations
13F Activity (30d)
217 filings
199 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2022-05-12 | — | |
| 6-K | 2022-05-13 | — | |
| 6-K | 2022-05-16 | — | |
| 6-K | 2022-05-19 | — | |
| 6-K | 2022-05-23 | — | |
| 6-K | 2022-05-25 | — | |
| 6-K | 2022-05-27 | 2022-05-26 | |
| 6-K | 2022-05-31 | — | |
| 6-K | 2022-06-01 | — | |
| 6-K | 2022-06-06 | — | |
| 6-K | 2022-06-07 | — | |
| 6-K | 2022-06-09 | — | |
| 6-K | 2022-06-10 | — | |
| 6-K | 2022-06-16 | — | |
| 6-K | 2022-06-24 | — | |
| 6-K | 2022-06-27 | — | |
| 6-K | 2022-06-28 | — | |
| 6-K | 2022-07-01 | — | |
| 6-K | 2022-07-05 | — | |
| 6-K | 2022-07-06 | — | |
| 6-K | 2022-07-08 | — | |
| 6-K | 2022-07-12 | — | |
| 6-K | 2022-07-18 | — | |
| 6-K | 2022-07-22 | — | |
| 6-K | 2022-07-27 | — | |
| 6-K | 2022-07-28 | — | |
| 6-K | 2022-07-29 | — | |
| 6-K | 2022-08-01 | — | |
| 6-K | 2022-08-03 | — | |
| 6-K | 2022-08-10 | — | |
| 6-K | 2022-08-11 | — | |
| 6-K | 2022-08-12 | — | |
| 6-K | 2022-08-16 | — | |
| 6-K | 2022-08-17 | — | |
| 6-K | 2022-08-22 | — | |
| 6-K | 2022-08-24 | — | |
| 6-K | 2022-09-01 | — | |
| 6-K | 2022-09-06 | — | |
| 6-K | 2022-09-08 | — | |
| 6-K | 2022-09-13 | — | |
| 6-K | 2022-09-21 | — | |
| 6-K | 2022-09-22 | — | |
| 6-K | 2022-09-26 | — | |
| 6-K | 2022-09-30 | — | |
| 6-K | 2022-10-03 | — | |
| 6-K | 2022-10-07 | — | |
| 6-K | 2022-10-11 | — | |
| 6-K | 2022-10-12 | — | |
| 6-K | 2022-10-13 | — | |
| 6-K | 2022-10-14 | — |
Showing 251–300 of 836 filings